Cholinergic Antagonists: Clinical Trials

3 trials of Cholinergic Antagonists, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 3
Phase 21Unknown 1

Follow Cholinergic Antagonists: new trials by email Literature Review of Cholinergic Antagonists trials Research Report on Cholinergic Antagonists

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children
Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin - Voiding Disorders, Overactive Bladder
Phase 1 / Phase 2UnknownMansoura University702022-02-012022-02-15
Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers.
Darifenacin - Bioequivalency
Phase 1UnknownCenter for Clinical Pharmacology Research Bdbeq S.A.242010-12-012010-10-27
Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.
Darifenacin - Bioequivalency
Phase 1UnknownCenter for Clinical Pharmacology Research Bdbeq S.A.242010-11-012010-10-25

Conditions studied

Urinary Bladder, Overactive (1)

Sponsors

Center for Clinical Pharmacology Research Bdbeq S.A. (2)  ·  Mansoura University (1)

Countries

Uruguay (2)

Top investigators

Francisco E. Estevez-Carrizo, MD (2)  ·  Susana Parrillo, M.D. (2)  ·  Islam Mansour, Mb ChB (1)